PHARMACOGENETIC FEATURES OF ZOLEDRONIC ACID IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
About the Authors
O. V. Yakushevskaya
National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov
Russian Federation
Russian Federation
S. V. Yureneva
National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov
Russian Federation
Russian Federation
S. Yu. Kuznetsov
National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov
Russian Federation
Russian Federation
G. T. Sukhikh
National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov
Russian Federation
Russian Federation
Review
For citations:
Yakushevskaya O.V., Yureneva S.V., Kuznetsov S.Yu., Sukhikh G.T. PHARMACOGENETIC FEATURES OF ZOLEDRONIC ACID IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS. Osteoporosis and Bone Diseases. 2020;23(2):206-207. (In Russ.)
Views:
206
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
